img

Global Human Papillomavirus Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Papillomavirus Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Human papilloma virus (HPV) vaccine is a vaccine that prevents infection by certain types of human papillomavirus.
Human Papillomavirus Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Papillomavirus Vaccine market is projected to reach US$ 2699.8 million in 2034, increasing from US$ 2154.1 million in 2022, with the CAGR of 2.8% during the period of 2024 to 2034. Demand from Cervical Cancer and Anal Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Human Papillomavirus Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Human Papillomavirus Vaccine key manufacturers include Merck, GlaxoSmithKline, Sanofi, Johnson & Johnson, AstraZeneca, Serum Institute, Wantai Biological, KM Biologics and Bharat Biotech, etc. Merck, GlaxoSmithKline, Sanofi are top 3 players and held % sales share in total in 2022.
Human Papillomavirus Vaccine can be divided into Bivalent, Quadrivalent and Nonavalent,, etc. Bivalent is the mainstream product in the market, accounting for % sales share globally in 2022.
Human Papillomavirus Vaccine is widely used in various fields, such as Cervical Cancer, Anal Cancer, Penile Cancer and Oropharyngeal Cancer, etc. Cervical Cancer provides greatest supports to the Human Papillomavirus Vaccine industry development. In 2022, global % sales of Human Papillomavirus Vaccine went into Cervical Cancer filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Papillomavirus Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
GlaxoSmithKline
Sanofi
Johnson & Johnson
AstraZeneca
Serum Institute
Wantai Biological
KM Biologics
Bharat Biotech
Segment by Type
Bivalent
Quadrivalent
Nonavalent

Segment by Application


Cervical Cancer
Anal Cancer
Penile Cancer
Oropharyngeal Cancer
Genital Warts
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Human Papillomavirus Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Papillomavirus Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Papillomavirus Vaccine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Human Papillomavirus Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Papillomavirus Vaccine introduction, etc. Human Papillomavirus Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Human Papillomavirus Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Human Papillomavirus Vaccine Market Overview
1.1 Human Papillomavirus Vaccine Product Overview
1.2 Human Papillomavirus Vaccine Market Segment by Type
1.2.1 Bivalent
1.2.2 Quadrivalent
1.2.3 Nonavalent
1.3 Global Human Papillomavirus Vaccine Market Size by Type
1.3.1 Global Human Papillomavirus Vaccine Market Size Overview by Type (2024-2034)
1.3.2 Global Human Papillomavirus Vaccine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Human Papillomavirus Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Papillomavirus Vaccine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Human Papillomavirus Vaccine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Human Papillomavirus Vaccine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Human Papillomavirus Vaccine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Human Papillomavirus Vaccine Sales Breakdown by Type (2024-2024)
2 Global Human Papillomavirus Vaccine Market Competition by Company
2.1 Global Top Players by Human Papillomavirus Vaccine Sales (2024-2024)
2.2 Global Top Players by Human Papillomavirus Vaccine Revenue (2024-2024)
2.3 Global Top Players by Human Papillomavirus Vaccine Price (2024-2024)
2.4 Global Top Manufacturers Human Papillomavirus Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Papillomavirus Vaccine Market Competitive Situation and Trends
2.5.1 Human Papillomavirus Vaccine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Papillomavirus Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Papillomavirus Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Human Papillomavirus Vaccine Market
2.8 Key Manufacturers Human Papillomavirus Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Papillomavirus Vaccine Status and Outlook by Region
3.1 Global Human Papillomavirus Vaccine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Human Papillomavirus Vaccine Historic Market Size by Region
3.2.1 Global Human Papillomavirus Vaccine Sales in Volume by Region (2024-2024)
3.2.2 Global Human Papillomavirus Vaccine Sales in Value by Region (2024-2024)
3.2.3 Global Human Papillomavirus Vaccine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Human Papillomavirus Vaccine Forecasted Market Size by Region
3.3.1 Global Human Papillomavirus Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Human Papillomavirus Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Human Papillomavirus Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Human Papillomavirus Vaccine by Application
4.1 Human Papillomavirus Vaccine Market Segment by Application
4.1.1 Cervical Cancer
4.1.2 Anal Cancer
4.1.3 Penile Cancer
4.1.4 Oropharyngeal Cancer
4.1.5 Genital Warts
4.1.6 Others
4.2 Global Human Papillomavirus Vaccine Market Size by Application
4.2.1 Global Human Papillomavirus Vaccine Market Size Overview by Application (2024-2034)
4.2.2 Global Human Papillomavirus Vaccine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Human Papillomavirus Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Papillomavirus Vaccine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Human Papillomavirus Vaccine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Human Papillomavirus Vaccine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Human Papillomavirus Vaccine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Human Papillomavirus Vaccine Sales Breakdown by Application (2024-2024)
5 North America Human Papillomavirus Vaccine by Country
5.1 North America Human Papillomavirus Vaccine Historic Market Size by Country
5.1.1 North America Human Papillomavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Human Papillomavirus Vaccine Sales in Volume by Country (2024-2024)
5.1.3 North America Human Papillomavirus Vaccine Sales in Value by Country (2024-2024)
5.2 North America Human Papillomavirus Vaccine Forecasted Market Size by Country
5.2.1 North America Human Papillomavirus Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Human Papillomavirus Vaccine Sales in Value by Country (2024-2034)
6 Europe Human Papillomavirus Vaccine by Country
6.1 Europe Human Papillomavirus Vaccine Historic Market Size by Country
6.1.1 Europe Human Papillomavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Human Papillomavirus Vaccine Sales in Volume by Country (2024-2024)
6.1.3 Europe Human Papillomavirus Vaccine Sales in Value by Country (2024-2024)
6.2 Europe Human Papillomavirus Vaccine Forecasted Market Size by Country
6.2.1 Europe Human Papillomavirus Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Human Papillomavirus Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Human Papillomavirus Vaccine by Region
7.1 Asia-Pacific Human Papillomavirus Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Human Papillomavirus Vaccine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Human Papillomavirus Vaccine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Human Papillomavirus Vaccine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Human Papillomavirus Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Papillomavirus Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Human Papillomavirus Vaccine Sales in Value by Region (2024-2034)
8 Latin America Human Papillomavirus Vaccine by Country
8.1 Latin America Human Papillomavirus Vaccine Historic Market Size by Country
8.1.1 Latin America Human Papillomavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Human Papillomavirus Vaccine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Human Papillomavirus Vaccine Sales in Value by Country (2024-2024)
8.2 Latin America Human Papillomavirus Vaccine Forecasted Market Size by Country
8.2.1 Latin America Human Papillomavirus Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Human Papillomavirus Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Human Papillomavirus Vaccine by Country
9.1 Middle East and Africa Human Papillomavirus Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Human Papillomavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Human Papillomavirus Vaccine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Human Papillomavirus Vaccine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Human Papillomavirus Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Papillomavirus Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Human Papillomavirus Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Merck Human Papillomavirus Vaccine Products Offered
10.1.5 Merck Recent Development
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Company Information
10.2.2 GlaxoSmithKline Introduction and Business Overview
10.2.3 GlaxoSmithKline Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 GlaxoSmithKline Human Papillomavirus Vaccine Products Offered
10.2.5 GlaxoSmithKline Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Sanofi Human Papillomavirus Vaccine Products Offered
10.3.5 Sanofi Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Johnson & Johnson Human Papillomavirus Vaccine Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.5.4 AstraZeneca Human Papillomavirus Vaccine Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Serum Institute
10.6.1 Serum Institute Company Information
10.6.2 Serum Institute Introduction and Business Overview
10.6.3 Serum Institute Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Serum Institute Human Papillomavirus Vaccine Products Offered
10.6.5 Serum Institute Recent Development
10.7 Wantai Biological
10.7.1 Wantai Biological Company Information
10.7.2 Wantai Biological Introduction and Business Overview
10.7.3 Wantai Biological Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Wantai Biological Human Papillomavirus Vaccine Products Offered
10.7.5 Wantai Biological Recent Development
10.8 KM Biologics
10.8.1 KM Biologics Company Information
10.8.2 KM Biologics Introduction and Business Overview
10.8.3 KM Biologics Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.8.4 KM Biologics Human Papillomavirus Vaccine Products Offered
10.8.5 KM Biologics Recent Development
10.9 Bharat Biotech
10.9.1 Bharat Biotech Company Information
10.9.2 Bharat Biotech Introduction and Business Overview
10.9.3 Bharat Biotech Human Papillomavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Bharat Biotech Human Papillomavirus Vaccine Products Offered
10.9.5 Bharat Biotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Papillomavirus Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Papillomavirus Vaccine Industrial Chain Analysis
11.4 Human Papillomavirus Vaccine Market Dynamics
11.4.1 Human Papillomavirus Vaccine Industry Trends
11.4.2 Human Papillomavirus Vaccine Market Drivers
11.4.3 Human Papillomavirus Vaccine Market Challenges
11.4.4 Human Papillomavirus Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Papillomavirus Vaccine Distributors
12.3 Human Papillomavirus Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Bivalent
Table 2. Major Company of Quadrivalent
Table 3. Major Company of Nonavalent
Table 4. Global Human Papillomavirus Vaccine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Human Papillomavirus Vaccine Sales by Type (2024-2024) & (K Doses)
Table 6. Global Human Papillomavirus Vaccine Sales Market Share in Volume by Type (2024-2024)
Table 7. Global Human Papillomavirus Vaccine Sales by Type (2024-2024) & (US& Million)
Table 8. Global Human Papillomavirus Vaccine Market Share in Value by Type (2024-2024)
Table 9. Global Human Papillomavirus Vaccine Price by Type (2024-2024) & (USD/Dose)
Table 10. Global Human Papillomavirus Vaccine Sales by Type (2024-2034) & (K Doses)
Table 11. Global Human Papillomavirus Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Human Papillomavirus Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Human Papillomavirus Vaccine Sales Market Share in Value by Type (2024-2034)
Table 14. Global Human Papillomavirus Vaccine Price by Type (2024-2034) & (USD/Dose)
Table 15. North America Human Papillomavirus Vaccine Sales by Type (2024-2024) & (K Doses)
Table 16. North America Human Papillomavirus Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe Human Papillomavirus Vaccine Sales (K Doses) by Type (2024-2024)
Table 18. Europe Human Papillomavirus Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific Human Papillomavirus Vaccine Sales (K Doses) by Type (2024-2024)
Table 20. Asia-Pacific Human Papillomavirus Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America Human Papillomavirus Vaccine Sales (K Doses) by Type (2024-2024)
Table 22. Latin America Human Papillomavirus Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa Human Papillomavirus Vaccine Sales (K Doses) by Type (2024-2024)
Table 24. Middle East and Africa Human Papillomavirus Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 25. Global Human Papillomavirus Vaccine Sales by Company (2024-2024) & (K Doses)
Table 26. Global Human Papillomavirus Vaccine Sales Share by Company (2024-2024)
Table 27. Global Human Papillomavirus Vaccine Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global Human Papillomavirus Vaccine Revenue Share by Company (2024-2024)
Table 29. Global Market Human Papillomavirus Vaccine Price by Company (2024-2024) & (USD/Dose)
Table 30. Global Human Papillomavirus Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Human Papillomavirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Papillomavirus Vaccine as of 2022)
Table 33. Date of Key Manufacturers Enter into Human Papillomavirus Vaccine Market
Table 34. Key Manufacturers Human Papillomavirus Vaccine Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Human Papillomavirus Vaccine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global Human Papillomavirus Vaccine Sales by Region (2024-2024) & (K Doses)
Table 38. Global Human Papillomavirus Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 39. Global Human Papillomavirus Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 40. Global Human Papillomavirus Vaccine Sales Market Share in Value by Region (2024-2024)
Table 41. Global Human Papillomavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 42. Global Human Papillomavirus Vaccine Sales by Region (2024-2034) & (K Doses)
Table 43. Global Human Papillomavirus Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Human Papillomavirus Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Human Papillomavirus Vaccine Sales Market Share in Value by Region (2024-2034)
Table 46. Global Human Papillomavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2034)
Table 47. Global Human Papillomavirus Vaccine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global Human Papillomavirus Vaccine Sales by Application (2024-2024) & (K Doses)
Table 49. Global Human Papillomavirus Vaccine Sales Market Share in Volume by Application (2024-2024)
Table 50. Global Human Papillomavirus Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 51. Global Human Papillomavirus Vaccine Sales Market Share in Value by Application (2024-2024)
Table 52. Global Human Papillomavirus Vaccine Price by Application (2024-2024) & (USD/Dose)
Table 53. Global Human Papillomavirus Vaccine Sales by Application (2024-2034) & (K Doses)
Table 54. Global Human Papillomavirus Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Human Papillomavirus Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Human Papillomavirus Vaccine Sales Market Share in Value by Application (2024-2034)
Table 57. Global Human Papillomavirus Vaccine Price by Application (2024-2034) & (USD/Dose)
Table 58. North America Human Papillomavirus Vaccine Sales by Application (2024-2024) (K Doses)
Table 59. North America Human Papillomavirus Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe Human Papillomavirus Vaccine Sales by Application (2024-2024) (K Doses)
Table 61. Europe Human Papillomavirus Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific Human Papillomavirus Vaccine Sales by Application (2024-2024) (K Doses)
Table 63. Asia-Pacific Human Papillomavirus Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America Human Papillomavirus Vaccine Sales by Application (2024-2024) (K Doses)
Table 65. Latin America Human Papillomavirus Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa Human Papillomavirus Vaccine Sales by Application (2024-2024) (K Doses)
Table 67. Middle East and Africa Human Papillomavirus Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 68. North America Human Papillomavirus Vaccine Sales by Country (2024-2024) & (K Doses)
Table 69. North America Human Papillomavirus Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 70. North America Human Papillomavirus Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 71. North America Human Papillomavirus Vaccine Sales Market Share in Value by Country (2024-2024)
Table 72. North America Human Papillomavirus Vaccine Sales by Country (2024-2034) & (K Doses)
Table 73. North America Human Papillomavirus Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Human Papillomavirus Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Human Papillomavirus Vaccine Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Human Papillomavirus Vaccine Sales by Country (2024-2024) & (K Doses)
Table 77. Europe Human Papillomavirus Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe Human Papillomavirus Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe Human Papillomavirus Vaccine Sales Market Share in Value by Country (2024-2024)
Table 80. Europe Human Papillomavirus Vaccine Sales by Country (2024-2034) & (K Doses)
Table 81. Europe Human Papillomavirus Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Human Papillomavirus Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Human Papillomavirus Vaccine Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Human Papillomavirus Vaccine Sales by Region (2024-2024) & (K Doses)
Table 85. Asia-Pacific Human Papillomavirus Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific Human Papillomavirus Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific Human Papillomavirus Vaccine Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific Human Papillomavirus Vaccine Sales by Region (2024-2034) & (K Doses)
Table 89. Asia-Pacific Human Papillomavirus Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Human Papillomavirus Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Human Papillomavirus Vaccine Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Human Papillomavirus Vaccine Sales by Country (2024-2024) & (K Doses)
Table 93. Latin America Human Papillomavirus Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America Human Papillomavirus Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America Human Papillomavirus Vaccine Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America Human Papillomavirus Vaccine Sales by Country (2024-2034) & (K Doses)
Table 97. Latin America Human Papillomavirus Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Human Papillomavirus Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Human Papillomavirus Vaccine Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Human Papillomavirus Vaccine Sales by Country (2024-2024) & (K Doses)
Table 101. Middle East and Africa Human Papillomavirus Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa Human Papillomavirus Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa Human Papillomavirus Vaccine Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa Human Papillomavirus Vaccine Sales by Country (2024-2034) & (K Doses)
Table 105. Middle East and Africa Human Papillomavirus Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Human Papillomavirus Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Human Papillomavirus Vaccine Sales Market Share in Value by Country (2024-2034)
Table 108. Merck Company Information
Table 109. Merck Introduction and Business Overview
Table 110. Merck Human Papillomavirus Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 111. Merck Human Papillomavirus Vaccine Product
Table 112. Merck Recent Development
Table 113. GlaxoSmithKline Company Information
Table 114. GlaxoSmithKline Introduction and Business Overview
Table 115. GlaxoSmithKline Human Papillomavirus Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 116. GlaxoSmithKline Human Papillomavirus Vaccine Product
Table 117. GlaxoSmithKline Recent Development
Table 118. Sanofi Company Information
Table 119. Sanofi Introduction and Business Overview
Table 120. Sanofi Human Papillomavirus Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 121. Sanofi Human Papillomavirus Vaccine Product
Table 122. Sanofi Recent Development
Table 123. Johnson & Johnson Company Information
Table 124. Johnson & Johnson Introduction and Business Overview
Table 125. Johnson & Johnson Human Papillomavirus Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 126. Johnson & Johnson Human Papillomavirus Vaccine Product
Table 127. Johnson & Johnson Recent Development
Table 128. AstraZeneca Company Information
Table 129. AstraZeneca Introduction and Business Overview
Table 130. AstraZeneca Human Papillomavirus Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 131. AstraZeneca Human Papillomavirus Vaccine Product
Table 132. AstraZeneca Recent Development
Table 133. Serum Institute Company Information
Table 134. Serum Institute Introduction and Business Overview
Table 135. Serum Institute Human Papillomavirus Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 136. Serum Institute Human Papillomavirus Vaccine Product
Table 137. Serum Institute Recent Development
Table 138. Wantai Biological Company Information
Table 139. Wantai Biological Introduction and Business Overview
Table 140. Wantai Biological Human Papillomavirus Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 141. Wantai Biological Human Papillomavirus Vaccine Product
Table 142. Wantai Biological Recent Development
Table 143. KM Biologics Company Information
Table 144. KM Biologics Introduction and Business Overview
Table 145. KM Biologics Human Papillomavirus Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 146. KM Biologics Human Papillomavirus Vaccine Product
Table 147. KM Biologics Recent Development
Table 148. Bharat Biotech Company Information
Table 149. Bharat Biotech Introduction and Business Overview
Table 150. Bharat Biotech Human Papillomavirus Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 151. Bharat Biotech Human Papillomavirus Vaccine Product
Table 152. Bharat Biotech Recent Development
Table 153. Key Raw Materials Lists
Table 154. Raw Materials Key Suppliers Lists
Table 155. Human Papillomavirus Vaccine Market Trends
Table 156. Human Papillomavirus Vaccine Market Drivers
Table 157. Human Papillomavirus Vaccine Market Challenges
Table 158. Human Papillomavirus Vaccine Market Restraints
Table 159. Human Papillomavirus Vaccine Distributors List
Table 160. Human Papillomavirus Vaccine Downstream Customers
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Papillomavirus Vaccine Product Picture
Figure 2. Global Human Papillomavirus Vaccine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Human Papillomavirus Vaccine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Human Papillomavirus Vaccine Sales Status and Outlook (2024-2034) & (K Doses)
Figure 5. Product Picture of Bivalent
Figure 6. Global Bivalent Sales YoY Growth (2024-2034) & (K Doses)
Figure 7. Product Picture of Quadrivalent
Figure 8. Global Quadrivalent Sales YoY Growth (2024-2034) & (K Doses)
Figure 9. Product Picture of Nonavalent
Figure 10. Global Nonavalent Sales YoY Growth (2024-2034) & (K Doses)
Figure 11. Global Human Papillomavirus Vaccine Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global Human Papillomavirus Vaccine Sales Market Share by Type in 2022 & 2034
Figure 13. North America Human Papillomavirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. North America Human Papillomavirus Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Europe Human Papillomavirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Europe Human Papillomavirus Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Human Papillomavirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Human Papillomavirus Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Latin America Human Papillomavirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Human Papillomavirus Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Human Papillomavirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Human Papillomavirus Vaccine Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Papillomavirus Vaccine Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Papillomavirus Vaccine Revenue in 2022
Figure 25. Human Papillomavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Cervical Cancer
Figure 27. Global Cervical Cancer Sales YoY Growth (2024-2034) & (K Doses)
Figure 28. Product Picture of Anal Cancer
Figure 29. Global Anal Cancer Sales YoY Growth (2024-2034) & (K Doses)
Figure 30. Product Picture of Penile Cancer
Figure 31. Global Penile Cancer Sales YoY Growth (2024-2034) & (K Doses)
Figure 32. Product Picture of Oropharyngeal Cancer
Figure 33. Global Oropharyngeal Cancer Sales YoY Growth (2024-2034) & (K Doses)
Figure 34. Product Picture of Genital Warts
Figure 35. Global Genital Warts Sales YoY Growth (2024-2034) & (K Doses)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2024-2034) & (K Doses)
Figure 38. Global Human Papillomavirus Vaccine Sales by Application (2024-2034) & (US$ Million)
Figure 39. Global Human Papillomavirus Vaccine Sales Market Share by Application in 2022 & 2034
Figure 40. North America Human Papillomavirus Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. North America Human Papillomavirus Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Europe Human Papillomavirus Vaccine Sales Market Share in Volume by Application in 2022
Figure 43. Europe Human Papillomavirus Vaccine Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Human Papillomavirus Vaccine Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Human Papillomavirus Vaccine Sales Market Share in Value by Application in 2022
Figure 46. Latin America Human Papillomavirus Vaccine Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Human Papillomavirus Vaccine Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Human Papillomavirus Vaccine Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Human Papillomavirus Vaccine Manufacturing Cost Structure
Figure 51. Human Papillomavirus Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries